Brugnolo, Francesca <br/><br/>
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Feb 2003 
 - 380-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1067/mai.2003.102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Adult<br/>Allergens<br/>Ampicillin--adverse effects<br/>Animals<br/>Antigens, Dermatophagoides--immunology<br/>Arthropod Proteins<br/>Cell Line<br/>Cysteine Endopeptidases<br/>Cytokines--biosynthesis<br/>Drug Hypersensitivity--immunology<br/>Humans<br/>Hypersensitivity, Immediate--immunology<br/>Imidazoles--pharmacology<br/>In Vitro Techniques<br/>Interferon-gamma--biosynthesis<br/>Models, Immunological<br/>T-Lymphocyte Subsets--drug effects<br/>Th1 Cells--drug effects<br/>Th2 Cells--drug effects